Central neuraxial block and low molecular weight heparin (enoxaparine): lessons learned from different dosage regimes in two continents.
Tryba
M
M
Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, City Hospital Kassel, Germany.
Wedel
D J
DJ
D016907:Adverse Drug Reaction Reporting Systems; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000767:Anesthesia, Epidural / Q000009:adverse effects*; D000775:Anesthesia, Spinal / Q000009:adverse effects*; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D017984:Enoxaparin / Q000008:administration & dosage / Q000009:adverse effects*; D005060:Europe; D005260:Female; D006407:Hematoma, Epidural, Cranial / Q000209:etiology*; D006801:Humans; D007796:Laminectomy; D008297:Male; D009407:Nerve Block / Q000009:adverse effects; D019106:Postoperative Hemorrhage / Q000209:etiology; D012307:Risk Factors; D014481:United States
D000925:Anticoagulants; D017984:Enoxaparin